NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0004 (400.00%)
Jan 22, 2026, 9:30 AM EST
NovAccess Global Market Cap
NovAccess Global has a market cap or net worth of $30.95 thousand as of January 23, 2026. Its market cap has decreased by -94.83% in one year.
Market Cap
30.95K
Enterprise Value
7.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 1998, NovAccess Global's market cap has decreased from 26.88M to 30.95K, a decrease of -99.88%. That is a compound annual growth rate of -21.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 30.95K | 399.97% |
| Dec 31, 2025 | 6.19K | -99.00% |
| Dec 31, 2024 | 619.07K | 28.89% |
| Dec 29, 2023 | 480.31K | -91.60% |
| Dec 30, 2022 | 5.72M | 10.69% |
| Dec 31, 2021 | 5.17M | 66.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelesis Holdings | 7.33K |
| Statera Biopharma | 7.26K |
| Therapeutic Solutions International | 7.05K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| Syros Pharmaceuticals | 5.37K |